775 related articles for article (PubMed ID: 25104775)
1. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice.
Knight JS; Subramanian V; O'Dell AA; Yalavarthi S; Zhao W; Smith CK; Hodgin JB; Thompson PR; Kaplan MJ
Ann Rheum Dis; 2015 Dec; 74(12):2199-206. PubMed ID: 25104775
[TBL] [Abstract][Full Text] [Related]
2. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus.
Knight JS; Zhao W; Luo W; Subramanian V; O'Dell AA; Yalavarthi S; Hodgin JB; Eitzman DT; Thompson PR; Kaplan MJ
J Clin Invest; 2013 Jul; 123(7):2981-93. PubMed ID: 23722903
[TBL] [Abstract][Full Text] [Related]
3. Polydatin effectively attenuates disease activity in lupus-prone mouse models by blocking ROS-mediated NET formation.
Liao P; He Y; Yang F; Luo G; Zhuang J; Zhai Z; Zhuang L; Lin Z; Zheng J; Sun E
Arthritis Res Ther; 2018 Nov; 20(1):254. PubMed ID: 30419963
[TBL] [Abstract][Full Text] [Related]
4. Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-
Fortner KA; Blanco LP; Buskiewicz I; Huang N; Gibson PC; Cook DL; Pedersen HL; Yuen PST; Murphy MP; Perl A; Kaplan MJ; Budd RC
Lupus Sci Med; 2020 Apr; 7(1):. PubMed ID: 32343673
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus-Prone Mice.
Oaks Z; Winans T; Caza T; Fernandez D; Liu Y; Landas SK; Banki K; Perl A
Arthritis Rheumatol; 2016 Nov; 68(11):2728-2739. PubMed ID: 27332042
[TBL] [Abstract][Full Text] [Related]
6. Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction.
Furumoto Y; Smith CK; Blanco L; Zhao W; Brooks SR; Thacker SG; Abdalrahman Z; Sciumè G; Tsai WL; Trier AM; Nunez L; Mast L; Hoffmann V; Remaley AT; O'Shea JJ; Kaplan MJ; Gadina M
Arthritis Rheumatol; 2017 Jan; 69(1):148-160. PubMed ID: 27429362
[TBL] [Abstract][Full Text] [Related]
7. Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7-dependent lupus.
Liu Y; Lightfoot YL; Seto N; Carmona-Rivera C; Moore E; Goel R; O'Neil L; Mistry P; Hoffmann V; Mondal S; Premnath PN; Gribbons K; Dell'Orso S; Jiang K; Thompson PR; Sun HW; Coonrod SA; Kaplan MJ
JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518690
[TBL] [Abstract][Full Text] [Related]
8. PDTC attenuate LPS-induced kidney injury in systemic lupus erythematosus-prone MRL/lpr mice.
Zhai JX; Zhang ZX; Feng YJ; Ding SS; Wang XH; Zou LW; Ye DQ
Mol Biol Rep; 2012 Jun; 39(6):6763-71. PubMed ID: 22318546
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
10. Activated protein C attenuates systemic lupus erythematosus and lupus nephritis in MRL-Fas(lpr) mice.
Lichtnekert J; Rupanagudi KV; Kulkarni OP; Darisipudi MN; Allam R; Anders HJ
J Immunol; 2011 Sep; 187(6):3413-21. PubMed ID: 21849682
[TBL] [Abstract][Full Text] [Related]
11. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice.
Atkinson C; Qiao F; Song H; Gilkeson GS; Tomlinson S
J Immunol; 2008 Jan; 180(2):1231-8. PubMed ID: 18178863
[TBL] [Abstract][Full Text] [Related]
12. At the Bedside: Neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases.
Barnado A; Crofford LJ; Oates JC
J Leukoc Biol; 2016 Feb; 99(2):265-78. PubMed ID: 26658004
[TBL] [Abstract][Full Text] [Related]
13. Amelioration of nephritis in receptor for advanced glycation end-products (RAGE)-deficient lupus-prone mice through neutrophil extracellular traps.
Watanabe H; Kubo M; Taniguchi A; Asano Y; Hiramatsu-Asano S; Ohashi K; Zeggar S; Katsuyama E; Katsuyama T; Sunahori-Watanabe K; Sada KE; Matsumoto Y; Yamamoto Y; Yamamoto H; Son M; Wada J
Clin Immunol; 2023 May; 250():109317. PubMed ID: 37015317
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide alleviates kidney injury and pregnancy outcomes in lupus-prone MRL/lpr mice treated with lipopolysaccharide.
Imaruoka K; Oe Y; Fushima T; Sato E; Sekimoto A; Sato H; Sugawara J; Ito S; Takahashi N
Biochem Biophys Res Commun; 2019 Mar; 510(4):587-593. PubMed ID: 30739788
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
Jiang C; Zhao ML; Scearce RM; Diaz M
Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
[TBL] [Abstract][Full Text] [Related]
16. B cell and/or autoantibody deficiency do not prevent neuropsychiatric disease in murine systemic lupus erythematosus.
Wen J; Doerner J; Chalmers S; Stock A; Wang H; Gullinello M; Shlomchik MJ; Putterman C
J Neuroinflammation; 2016 Apr; 13(1):73. PubMed ID: 27055816
[TBL] [Abstract][Full Text] [Related]
17. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil Extracellular Traps Drive Endothelial-to-Mesenchymal Transition.
Pieterse E; Rother N; Garsen M; Hofstra JM; Satchell SC; Hoffmann M; Loeven MA; Knaapen HK; van der Heijden OWH; Berden JHM; Hilbrands LB; van der Vlag J
Arterioscler Thromb Vasc Biol; 2017 Jul; 37(7):1371-1379. PubMed ID: 28495931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
